Bpifrance SA - Q1 2023 holdings

$3.89 Billion is the total value of Bpifrance SA's 8 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 14.3% .

 Value Shares↓ Weighting
STLA  STELLANTIS NV$3,505,611,665
+28.5%
192,703,9070.0%90.19%
+0.4%
CSTM  CONSTELLIUM NVcl a$250,498,838
+29.2%
16,393,9030.0%6.44%
+0.9%
CRTO SellCRITEO S Aspons ads$84,908,936
+19.8%
2,695,094
-0.9%
2.18%
-6.4%
VECT  VECTIVBIO HOLDING AG$23,880,907
-1.8%
2,806,2170.0%0.61%
-23.3%
 MIRION TECHNOLOGIES INC$10,986,249
+29.2%
1,286,4460.0%0.28%
+1.1%
SQNS  SEQUANSCOMMUNICATIONS S Aspons ads$6,600,036
-39.8%
3,300,0180.0%0.17%
-52.9%
CLLS NewCELLECTIS S.A.$4,220,8332,186,960
+100.0%
0.11%
 GETAROUND INC$184,625
-56.3%
647,8080.0%0.01%
-64.3%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CRITEO S A20Q3 202310.1%
TECHNIPFMC PLC13Q4 202168.1%
STELLANTIS NV11Q3 202390.9%
CONSTELLIUM NV11Q2 202141.6%
SEQUANS COMMUNICATIONS S A11Q2 20215.8%
CELLECTIS S.A.10Q2 20232.3%
CONSTELLIUM NV9Q3 20238.3%
SEQUANSCOMMUNICATIONS S A9Q3 20230.5%
MILLENDO THERAPEUTICS INC8Q3 20201.8%
VECTIVBIO HOLDING AG8Q1 20230.8%

View Bpifrance SA's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-07
13F-HR2023-11-13
13F-HR2023-07-28
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-11
13F-HR2022-05-16
13F-HR2022-02-11
13F-HR2021-11-15

View Bpifrance SA's complete filings history.

Compare quarters

Export Bpifrance SA's holdings